Abstract
PurposeBecause of the involvement of type 1 interferon (IFN-1) in the pathophysiology of both systemic lupus erythematosus (SLE) and COVID-19 immune response, a risk of post COVID-19 SLE flare could...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
